Asthra AI

🗓 Founded 2024👥 6 employees💰 Last funded Sep 2025
Asthra is the chat-native studio for regulatory writers. Life-sciences teams generate, refine, search, review, and QC first drafts of CSRs, PSURs, CERs, clinical trial protocols, Investigators Brochures, and more — in one conversation, inside Microsoft Word. The agent lives in your draft: it plans which sources to use, retrieves only from your own documents, drafts each section against your house rules, and cites every claim at the sentence level. What makes Asthra different: • One conversation, one document — generate, refine, search, and review without switching tools. • Walk-away drafting — start a run, step away, and return in 1–2 hours to a first draft with bibliography, hyperlinks, and a QC report ready. • A dedicated QC agent — every run ships a structured quality report that cross-checks every claim against its sources and enforces cross-section consistency. • Reviewer personas — summon an FDA Clinical, CMC, CER Device, or CSR Writer QC reviewer over any section before the real review. • Audit-ready by construction — closed-system retrieval over your own sources, sentence-level citations, and a run bundle you can hand to an inspector. Built for regulated writing, not adapted to it. Part 11–ready architecture. SOC 2 ready. Your sources, your perimeter. Learn more: https://asthra-writer.ai
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded
Investor geography1 country
India
1
Frequently asked questions
Who invested in Asthra AI?
Asthra AI has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Asthra AI last raise funding?
The most recent investment in Asthra AI recorded on gritt.io was in September 2025.
When was Asthra AI founded?
Asthra AI was founded in 2024.
What industry is Asthra AI in?
Asthra AI operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.